The University of Oxford is set to begin large trials of its COVID-19 vaccine in the U.S.

Phase 3 clinical trials for the Oxford COVID-19 vaccine are set to begin in the US Tuesday.

COVID-19 vaccine are set to begin in the United States Tuesday, with participants in Madison, Wisconsin rolling up their sleeves for the injection.

But Dr. William Hartman, an assistant professor of anesthesiology at UW Health and the University of Wisconsin-Madison School of Medicine and Public Health, doesn't expect preliminary data until at least Thanksgiving. The first participant to sign up is UW's chief quality officer and an emergency medicine physician, Dr. Jeff Pothof. He's scheduled to get the shot on Tuesday, but is not otherwise involved in the research.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NBCNews /  🏆 10. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA: COVID Vaccine Could Be Given Before Tests EndEmergency use authorization or approval for a COVID-19 vaccine before Phase 3 clinical trials are complete could be considered by the U.S. Food and Drug Administratio
Read more »

Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccines'The US_FDA announced that a public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on Oct. 22, 2020, to discuss the general matter of the development, authorization, and/or licensure of [covid19 vaccines].'
Read more »

COVID-19 vaccine diplomacy: Mexico courts allies across ideological spectrumMexico is pressing ahead with an effort to forge COVID-19 vaccine alliances across a wide ideological spectrum of countries from France to Cuba as a World Health Organization (WHO) vaccine initiative will fall short of its needs.
Read more »

Explainer: How common cold viruses are being used in vaccines from Russia, ChinaThe modified common cold viruses behind high-profile COVID-19 vaccine candidates from China's CanSino Biologics and Russia's Gamaleya Institute have been studied for decades, but are still not widely used.
Read more »

FDA head open to authorizing a COVID-19 vaccine before end of phase 3.DrJohnTorres on FDA willing to fast track COVID-19 vaccine before phase 3 trials end: 'The concern is that they are kind of jumpstarting it a little bit ... that's what has a lot of experts concerned.'
Read more »